These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22222868)

  • 1. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
    González-Smith A; Vemulapalli R; Andrews E; Oñate A
    Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.
    Retamal-Díaz A; Riquelme-Neira R; Sáez D; Rivera A; Fernández P; Cabrera A; Guzmán CA; Oñate A
    Clin Vaccine Immunol; 2014 Nov; 21(11):1474-80. PubMed ID: 25165025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.
    Singha H; Mallick AI; Jana C; Isore DP; Goswami TK; Srivastava SK; Azevedo VA; Chaudhuri P; Owais M
    Microbes Infect; 2008; 10(10-11):1089-96. PubMed ID: 18602490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
    Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
    Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
    Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu-Zn superoxide dismutase protein against Brucella abortus.
    Singha H; Mallick AI; Jana C; Fatima N; Owais M; Chaudhuri P
    Vaccine; 2011 Jun; 29(29-30):4720-7. PubMed ID: 21565241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.
    Muñoz-Montesino C; Andrews E; Rivers R; González-Smith A; Moraga-Cid G; Folch H; Céspedes S; Oñate AA
    Infect Immun; 2004 Apr; 72(4):2081-7. PubMed ID: 15039330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
    Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.
    Shirdast H; Ebrahimzadeh F; Taromchi AH; Mortazavi Y; Esmaeilzadeh A; Sekhavati MH; Nedaei K; Mirabzadeh E
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):80-89. PubMed ID: 32661939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis.
    Gouran ST; Doosti A; Jami MS
    Vet Med Sci; 2023 Jul; 9(4):1908-1922. PubMed ID: 37276346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen.
    Pontes DS; Dorella FA; Ribeiro LA; Miyoshi A; Le Loir Y; Gruss A; Oliveira SC; Langella P; Azevedo V
    J Drug Target; 2003; 11(8-10):489-93. PubMed ID: 15203917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel vaccine strategy against Brucellosis using Brucella abortus multi-epitope OMPs vaccine based on Lactococcus lactis live bacterial vectors.
    Piri-Gharaghie T; Ghajari G; Rezaeizadeh G; Adil M; Mahdi MH
    Int Immunopharmacol; 2024 Jun; 134():112204. PubMed ID: 38703567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.